国际医学：募集资金使用专款专用，将关注脑机接口等前沿医学技术

Core Viewpoint - The company has confirmed that the funds raised from the private placement will be allocated specifically for the smart healthcare project, the second phase of the proton therapy center, and to supplement working capital, with no immediate plans to change the use of these funds for brain-computer interface research [1] Group 1 - The company responded to an investor inquiry regarding the potential change in the use of funds from the stock issuance, indicating that any significant adjustments to the fundraising plan must follow legal procedures [1] - The private placement has been approved by the company's board and shareholders, emphasizing the commitment to the original fundraising purposes [1] - The company expressed its ongoing interest in modern frontier medical technologies, including brain-computer interfaces, while maintaining a focus on building a high-level hospital [1]